EVERENCE CAPITAL MANAGEMENT INC - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
EVERENCE CAPITAL MANAGEMENT INC ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$181
-12.6%
10,0600.0%0.01%
-17.6%
Q2 2023$207
+13.1%
10,0600.0%0.02%
+13.3%
Q1 2023$183
-12.0%
10,0600.0%0.02%
-16.7%
Q4 2022$208
-99.9%
10,0600.0%0.02%
-25.0%
Q3 2022$263,000
+3.1%
10,0600.0%0.02%
+4.3%
Q2 2022$255,00010,0600.02%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$50,877,00022.64%
Octagon Capital Advisors LP 2,489,974$78,584,00016.99%
Decheng Capital Management III (Cayman), LLC 869,790$27,451,0008.41%
BVF INC/IL 3,960,948$125,008,0005.00%
PFM Health Sciences, LP 3,431,010$108,283,0004.05%
EcoR1 Capital, LLC 3,265,101$103,047,0003.22%
Alphabet Inc. 2,563,441$80,902,0002.62%
Boxer Capital, LLC 1,432,200$45,200,0002.32%
SECTORAL ASSET MANAGEMENT INC 338,480$10,682,0001.90%
PARK CIRCLE Co 64,000$2,020,0001.68%
View complete list of ARCUS BIOSCIENCES INC shareholders